Recruitment of neutrophils from the blood circulation to sites of infection or injury is a key innate immune response against invading pathogens and tissue injury. However, if inappropriately triggered, excessive and/or prolonged, this host defence response can also lead to severe pathological disorders. The migration of all leucocytes out of the vasculature is classically described by the leucocyte adhesion cascade that depicts a well-characterised sequence of cellular and molecular events within the vascular lumen. Recent findings have now illustrated that beyond the vascular lumen, the breaching of the venular wall can also involve an analogous cascade of adhesive events. For neutrophils this involves a tightly regulated and sequential series of responses within venular walls, initiating with adhesive steps that guide neutrophils through endothelial cells lining the venular wall, followed by responses that mediate and regulate their migration through the pericyte sheath and the venular basement membrane. The present review aims to provide a brief summary of novel additions to the classical adhesion cascade within the vascular lumen and then to discuss the emergence of a second adhesion cascade for neutrophils within venular walls, the latter illustrating the intricacies and complexities of neutrophil transmigration.

1.
Nemeth T, Mocsai A: The role of neutrophils in autoimmune diseases. Immunol Lett 2012;143:9-19.
2.
Ley K, Laudanna C, Cybulsky MI, Nourshargh S: Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007;7:678-689.
3.
Nourshargh S, Hordijk PL, Sixt M: Breaching multiple barriers: leukocyte motility through venular walls and the interstitium. Nat Rev Mol Cell Biol 2010;11:366-378.
4.
Bianchi ME: DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007;81:1-5.
5.
Takeuchi O, Akira S: Pattern recognition receptors and inflammation. Cell 2010;140:805-820.
6.
Sadik CD, Kim ND, Luster AD: Neutrophils cascading their way to inflammation. Trends Immunol 2011;32:452-460.
7.
McEver RP: Selectins: lectins that initiate cell adhesion under flow. Curr Opin Cell Biol 2002;14:581-586.
8.
Sundd P, Gutierrez E, Koltsova EK, Kuwano Y, Fukuda S, Pospieszalska MK, et al: ‘Slings' enable neutrophil rolling at high shear. Nature 2012;488:399-403.
9.
Zarbock A, Lowell CA, Ley K: Spleen tyrosine kinase Syk is necessary for E-selectin-induced alpha(L)beta(2) integrin-mediated rolling on intercellular adhesion molecule-1. Immunity 2007;26:773-783.
10.
Zarbock A, Ley K, McEver RP, Hidalgo A: Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. Blood 2011;118:6743-6751.
11.
Rot A: Chemokine patterning by glycosaminoglycans and interceptors. Front Biosci 2010;15:645-660.
12.
Pruenster M, Mudde L, Bombosi P, Dimitrova S, Zsak M, Middleton J, et al: The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat Immunol 2009;10:101-108.
13.
Lefort CT, Ley K: Neutrophil arrest by LFA-1 activation. Front Immunol 2012;3:157.
14.
Henderson RB, Lim LH, Tessier PA, Gavins FN, Mathies M, Perretti M, et al: The use of lymphocyte function-associated antigen (LFA)-1-deficient mice to determine the role of LFA-1, Mac-1, and alpha4 integrin in the inflammatory response of neutrophils. J Exp Med 2001;194:219-226.
15.
Reinhardt PH, Elliott JF, Kubes P: Neutrophils can adhere via alpha4beta1-integrin under flow conditions. Blood 1997;89:3837-3846.
16.
Williams MR, Azcutia V, Newton G, Alcaide P, Luscinskas FW: Emerging mechanisms of neutrophil recruitment across endothelium. Trends Immunol 2011;32:461-469.
17.
Phillipson M, Heit B, Colarusso P, Liu L, Ballantyne CM, Kubes P: Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascade. J Exp Med 2006;203:2569-2575.
18.
Phillipson M, Heit B, Parsons SA, Petri B, Mullaly SC, Colarusso P, et al: Vav1 is essential for mechanotactic crawling and migration of neutrophils out of the inflamed microvasculature. J Immunol 2009;182:6870-6878.
19.
Gakidis MA, Cullere X, Olson T, Wilsbacher JL, Zhang B, Moores SL, et al: Vav GEFs are required for beta2 integrin-dependent functions of neutrophils. J Cell Biol 2004;166:273-282.
20.
Vestweber D: Relevance of endothelial junctions in leukocyte extravasation and vascular permeability. Ann NY Acad Sci 2012;1257:184-192.
21.
Woodfin A, Voisin MB, Nourshargh S: Recent developments and complexities in neutrophil transmigration. Curr Opin Hematol 2010;17:9-17.
22.
Woodfin A, Voisin MB, Beyrau M, Colom B, Caille D, Diapouli FM, et al: The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo. Nat Immunol 2011;12:761-769.
23.
Schulte D, Kuppers V, Dartsch N, Broermann A, Li H, Zarbock A, et al: Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability. EMBO J 2011;30:4157-4170.
24.
Broermann A, Winderlich M, Block H, Frye M, Rossaint J, Zarbock A, et al: Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo. J Exp Med 2011;208:2393-2401.
25.
Allingham MJ, van Buul JD, Burridge K: ICAM-1-mediated, Src- and Pyk2-dependent vascular endothelial cadherin tyrosine phosphorylation is required for leukocyte transendothelial migration. J Immunol 2007;179:4053-4064.
26.
Marmon S, Hinchey J, Oh P, Cammer M, de Almeida CJ, Gunther L, et al: Caveolin-1 expression determines the route of neutrophil extravasation through skin microvasculature. Am J Pathol 2009;174:684-692.
27.
Liu G, Place AT, Chen Z, Brovkovych VM, Vogel SM, Muller WA, et al: ICAM-1-activated Src and eNOS signaling increase endothelial cell surface PECAM-1 adhesivity and neutrophil transmigration. Blood 2012;120:1942-1952.
28.
Mamdouh Z, Chen X, Pierini LM, Maxfield FR, Muller WA: Targeted recycling of PECAM from endothelial surface-connected compartments during diapedesis. Nature 2003;421:748-753.
29.
Nourshargh S, Krombach F, Dejana E: The role of JAM-A and PECAM-1 in modulating leukocyte infiltration in inflamed and ischemic tissues. J Leukoc Biol 2006;80:714-718.
30.
Scheiermann C, Colom B, Meda P, Patel NS, Voisin MB, Marrelli A, et al: Junctional adhesion molecule-C mediates leukocyte infiltration in response to ischemia reperfusion injury. Arterioscler Thromb Vasc Biol 2009;29:1509-1515.
31.
Mamdouh Z, Mikhailov A, Muller WA: Transcellular migration of leukocytes is mediated by the endothelial lateral border recycling compartment. J Exp Med 2009;206:2795-2808.
32.
Orlova VV, Economopoulou M, Lupu F, Santoso S, Chavakis T: Junctional adhesion molecule-C regulates vascular endothelial permeability by modulating VE-cadherin-mediated cell-cell contacts. J Exp Med 2006;203:2703-2714.
33.
Woodfin A, Voisin MB, Imhof BA, Dejana E, Engelhardt B, Nourshargh S: Endothelial cell activation leads to neutrophil transmigration as supported by the sequential roles of ICAM-2, JAM-A, and PECAM-1. Blood 2009;113:6246-6257.
34.
Cera MR, Fabbri M, Molendini C, Corada M, Orsenigo F, Rehberg M, et al: JAM-A promotes neutrophil chemotaxis by controlling integrin internalization and recycling. J Cell Sci 2009;122(pt 2):268-277.
35.
Yoo SK, Huttenlocher A: Spatiotemporal photolabeling of neutrophil trafficking during inflammation in live zebrafish. J Leukoc Biol 2011;89:661-667.
36.
Buckley CD, Ross EA, McGettrick HM, Osborne CE, Haworth O, Schmutz C, et al: Identification of a phenotypically and functionally distinct population of long-lived neutrophils in a model of reverse endothelial migration. J Leukoc Biol 2006;79:303-311.
37.
Armulik A, Genove G, Betsholtz C: Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 2011;21:193-215.
38.
Dahlman-Ghozlan K, Ortonne JP, Heilborn JD, Stephansson E: Altered tissue expression pattern of cell adhesion molecules, ICAM-1, E-selectin and VCAM-1, in bullous pemphigoid during methotrexate therapy. Exp Dermatol 2004;13:65-69.
39.
Kriegsmann J, Keyszer GM, Geiler T, Brauer R, Gay RE, Gay S: Expression of vascular cell adhesion molecule-1 mRNA and protein in rheumatoid synovium demonstrated by in situ hybridization and immunohistochemistry. Lab Invest 1995;72:209-214.
40.
Verbeek MM, Westphal JR, Ruiter DJ, de Waal RM: T lymphocyte adhesion to human brain pericytes is mediated via very late antigen-4/vascular cell adhesion molecule-1 interactions. J Immunol 1995;154:5876-5884.
41.
Maier CL, Pober JS: Human placental pericytes poorly stimulate and actively regulate allogeneic CD4 T cell responses. Arterioscler Thromb Vasc Biol 2011;31:183-189.
42.
Voisin MB, Probstl D, Nourshargh S: Venular basement membranes ubiquitously express matrix protein low-expression regions: characterization in multiple tissues and remodeling during inflammation. Am J Pathol 2010;176:482-495.
43.
Wang S, Voisin MB, Larbi KY, Dangerfield J, Scheiermann C, Tran M, et al: Venular basement membranes contain specific matrix protein low expression regions that act as exit points for emigrating neutrophils. J Exp Med 2006;203:1519-1532.
44.
Proebstl D, Voisin MB, Woodfin A, Whiteford J, D'Acquisto F, Jones GE, et al: Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo. J Exp Med 2012;209:1219-1234.
45.
Feng D, Nagy JA, Pyne K, Dvorak HF, Dvorak AM: Neutrophils emigrate from venules by a transendothelial cell pathway in response to FMLP. J Exp Med 1998;187:903-915.
46.
Sumagin R, Sarelius IH: Intercellular adhesion molecule-1 enrichment near tricellular endothelial junctions is preferentially associated with leukocyte transmigration and signals for reorganization of these junctions to accommodate leukocyte passage. J Immunol 2010;184:5242-5252.
47.
Soehnlein O, Lindbom L, Weber C: Mechanisms underlying neutrophil-mediated monocyte recruitment. Blood 2009;114:4613-4623.
48.
Mydel P, Shipley JM, Adair-Kirk TL, Kelley DG, Broekelmann TJ, Mecham RP, et al: Neutrophil elastase cleaves laminin-332 (laminin-5) generating peptides that are chemotactic for neutrophils. J Biol Chem 2008;283:9513-9522.
49.
Rowe RG, Weiss SJ: Breaching the basement membrane: who, when and how? Trends Cell Biol 2008;18:560-574.
50.
Hyun YM, Sumagin R, Sarangi PP, Lomakina E, Overstreet MG, Baker CM, et al: Uropod elongation is a common final step in leukocyte extravasation through inflamed vessels. J Exp Med 2012;209:1349-1362.
51.
Voisin MB, Woodfin A, Nourshargh S: Monocytes and neutrophils exhibit both distinct and common mechanisms in penetrating the vascular basement membrane in vivo. Arterioscler Thromb Vasc Biol 2009;29:1193-1199.
52.
Friedl P, Weigelin B: Interstitial leukocyte migration and immune function. Nat Immunol 2008;9:960-969.
53.
Stark K, Eckart A, Haidari S, Tirniceriu A, Lorenz M, von Bruhl ML, et al: Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and ‘instruct' them with pattern-recognition and motility programs 1. Nat Immunol 2013;14:41-51.
54.
Stramm LE, Li W, Aguirre GD, Rockey JH: Glycosaminoglycan synthesis and secretion by bovine retinal capillary pericytes in culture. Exp Eye Res 1987;44:17-28.
55.
Kowluru RA, Zhong Q, Kanwar M: Metabolic memory and diabetic retinopathy: role of inflammatory mediators in retinal pericytes. Exp Eye Res 2010;90:617-623.
56.
Fabry Z, Sandor M, Gajewski TF, Herlein JA, Waldschmidt MM, Lynch RG, Hart MN: Differential activation of Th1 and Th2 CD4+ cells by murine brain microvessel endothelial cells and smooth muscle/pericytes. J Immunol 1993;151:38-47.
57.
Balabanov R, Beaumont T, Dore-Duffy P: Role of central nervous system microvascular pericytes in activation of antigen-primed splenic T-lymphocytes. J Neurosci Res 1999; 55:578-587.
58.
Brady HR, Denton MD, Jimenez W, Takata S, Palliser D, Brenner BM: Chemoattractants provoke monocyte adhesion to human mesangial cells and mesangial cell injury. Kidney Int 1992;42:480-487.
59.
Dahlman-Ghozlan K, Ortonne JP, Heilborn JD, Stephansson E: Altered tissue expression pattern of cell adhesion molecules, ICAM-1, E-selectin and VCAM-1, in bullous pemphigoid during methotrexate therapy. Exp Dermatol 2004;13:65-69.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.